Table 4. Relative Frequency (%) of... | American Society of Hematology

Table 4.

Relative Frequency (%) of Complications During Induction Cycle I

	Control Group	GM-CSF
		Group
Hemorrhage
Only petechiae	21	26
Other bleedings	26	25
Liver
Mild-moderate (1.25-5 × normal)	31	37
Severe (≥5 × normal)	11	10
Oral
Erythema	17	14
Ulcers and other toxicity	7	12
Nausea/vomiting	30/35	32/34
Diarrhea^4-150
Less than 2 days	23	23
More severe	18	30
Renal^4-150
Mild-moderate (1.26-5 × normal)	21	31
Severe (≥5 × normal)	3	3
Fever^4-150
Subfebrile (<38°C)	12	11
≥38°C	71	81
Cutaneous^4-150
Erythema/desquamation/papules etc	43	55
Cardiac rhythm	22	22
Neurotoxicity	11	12
Bone pain	6	8
Hypotension^4-151	13	26
Fluid retention^‡	56	71
Chills^‡	18	37
Phlebitis^4-150	8	17
Infection	77	78

	Control Group	GM-CSF
		Group
Hemorrhage
Only petechiae	21	26
Other bleedings	26	25
Liver
Mild-moderate (1.25-5 × normal)	31	37
Severe (≥5 × normal)	11	10
Oral
Erythema	17	14
Ulcers and other toxicity	7	12
Nausea/vomiting	30/35	32/34
Diarrhea^4-150
Less than 2 days	23	23
More severe	18	30
Renal^4-150
Mild-moderate (1.26-5 × normal)	21	31
Severe (≥5 × normal)	3	3
Fever^4-150
Subfebrile (<38°C)	12	11
≥38°C	71	81
Cutaneous^4-150
Erythema/desquamation/papules etc	43	55
Cardiac rhythm	22	22
Neurotoxicity	11	12
Bone pain	6	8
Hypotension^4-151	13	26
Fluid retention^‡	56	71
Chills^‡	18	37
Phlebitis^4-150	8	17
Infection	77	78

P < .05.

P < .01.

P < .001.